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5-Hydroxy-L-tryptophan (5-HTP) is a naturally occurring aromatic amino acid present in the seeds of the African
plant Griffonia simplicifolia. Although 5-HTP has therapeutic effects in various symptoms, efficient method of
producing 5-HTP has not been established. In this study, we developed a novel cofactor regeneration process to
achieve enhanced synthesis of 5-HTP by using modified L-phenylalanine 4-hydroxylase of Chromobacterium
violaceum. For the synthesis of 5-HTP using Escherichia coli whole cell bioconversion, L-tryptophan and 5-HTP
degradation by E. coli endogenous catabolic enzymes should be considered. The tryptophanase gene was disrupted
using the λ red recombination system, since tryptophanase is postulated as an initial enzyme for the degradation of
L-tryptophan and 5-HTP in E. coli. For regeneration of the cofactor pterin, we screened and investigated several key
enzymes, including dihydropteridine reductase from E. coli, glucose dehydrogenase from Bacillus subtilis, and
pterin-4α-carbinolamine dehydratase from Pseudomonas syringae. Genes encoding these three enzymes were
overexpressed in an E. coli tryptophanase-deficient host, resulting in the synthesis of 0.74 mM 5-HTP in the presence
of 0.1 mM pterin and the synthesis of 0.07 mM 5-HTP in the absence of regeneration of pterin. These results clearly
indicated the successful regeneration of pterin. Following optimization of the reaction conditions, 2.5 mM 5-HTP
was synthesized with cofactor regeneration, while 0.8 mM 5-HTP was recovered without cofactor regeneration
under the same reaction conditions, suggesting that the principle described here provides a new method for
cofactor regeneration.
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5-Hydroxy-L-tryptophan (5-HTP) is a serotonin pathway
metabolite of L-tryptophan in the brain. 5-HTP controls
the concentration of serotonin, and therefore plays a
significant role in the serotonin pathway. In this pathway,
L-tryptophan is hydroxylated by tryptophan 5-hydroxylase
to form 5-HTP, following which aromatic amino acid
decarboxylase (Zhu and Juorio 1995) catalyzes the forma-
tion of 5-hydroxytryptamine (serotonin). The tryptophan
hydroxylation reaction has been identified as the rate-
limiting step in the serotonin pathway, and this reaction
regulates the formation of serotonin. Hence, serotonin
levels are elevated by oral administration of 5-HTP, lead-
ing to therapeutic effects in the case of various symptoms,* Correspondence: kkino@waseda.jp
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in any medium, provided the original work is pincluding depression (Angst et al. 1977; Persson and Roos
1967; Takahashi et al. 1975; van Praag and de Hann 1980),
chronic headache (Bono et al. 1984; Ribeiro 2000), and
insomnia (Guilleminault et al. 1973; Wyatt et al. 1971).
Moreover, 5-HTP acts as an antioxidant agent (Cadenas
et al. 1989; Lysek et al. 2003).
Numerous studies have reported the drug evaluation
and medicinal properties of 5-HTP; however, the produc-
tion of 5-HTP is currently dependent mainly on extraction
from the seeds of the African plant Griffonia simplicifolia.
This method is not suitable for efficient production of 5-
HTP; therefore, a more practical method providing better
yield is required. Alternatively, pterin-dependent aromatic
amino acid hydroxylases (Fitzpatrick 2000), which are
family of enzymes that require tetrahydropterin as a cofac-
tor, including phenylalanine hydroxylase, and both tyro-
sine and tryptophan hydroxylases (rate-limiting enzymes
for catecholamine and serotonin pathways, respectively),s an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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synthesizing hydroxy aromatic amino acids. These
enzymes are widely distributed throughout vertebrate
species, and the human pterin-dependent aromatic amino
acid hydroxylases in particular have been well elucidated.
Tryptophan 5-hydroxylase is capable of efficiently synthe-
sizing 5-HTP via the hydroxylation of L-tryptophan;
however, this method is not suitable for industrial use due
to low hydroxylation activity and poor stability when
expressed both in prokaryotes and eukaryotes (Wang
et al. 2002). In contrast, some prokaryotes, such as Chro-
mobacterium violaceum (Nakata et al. 1979; Onishi et al.
1991) and Pseudomonas aeruginosa (Zhao et al. 1994),
also produce L-phenylalanine 4-hydroxylase, but trypto-
phan 5-hydroxylase is not found in any of these microbes.
L-Phenylalanine 4-hydroxylase from C. violaceum
(CviPAH) can hydroxylate the C-5 position of L-trypto-
phan as well as the C-4 position of L-phenylalanine
(Fujisawa and Nakata 1987; Nakata et al. 1979; Pember
et al. 1987). However, the hydroxylation rate of L-trypto-
phan is relatively lower than that of L-phenylalanine
(~0.4%). In our previous study, we performed structure-
based rational designing of CviPAH, and the resulting
mutant enzyme, CviPAH-L101Y-W180F, exhibited a 5.2-
fold higher kcat value than the wild-type enzyme during
L-tryptophan hydroxylation (Kino et al. 2009). This
enzyme reaction should have high potential for practical
production of 5-HTP because no by-products are
formed, and the substrate, L-tryptophan, is available
through industrial microbial fermentation performed
using metabolically engineered Corynebacterium gluta-
micum (58 g/L) (Ikeda and Katsumata 1999) and Escher-
ichia coli (54.6 g/L) (Azuma et al. 1993), both of which
provide excellent yield. However, CviPAH-L101Y-W180F
still requires pterin as a cofactor for enzyme activity,
which is similar to the requirements of other types of
aromatic amino acid hydroxylases. We attempted to
regenerate the cofactor to overcome this problem, since
pterin is an expensive compound. Here, we report the
development of an enhanced L-tryptophan hydroxyl-
ation process coupled with regeneration of the cofactors
pterin and NAD(P)H. Pterin biosynthesis and regener-
ation are observed in mammals; therefore, we cloned
and reconstructed the corresponding enzymes derived
from various microorganisms in E. coli with the aim of
developing an enhanced enzymatic selective synthesis




chloride was purchased from Sigma (St. Louis, MO). All
other chemicals were of the highest analytical grade
available. Bacillus subtilis ATCC 23857 and genomicDNA of Pseudomonas syringae ATCC BAA-978D were
obtained from American Type Culture Collection.
Disruption of the chromosomal tnaA gene in E. coli
E. coli BL21(DE3) tnaA– was constructed using the λ
Red recombination system (Datsenko and Wanner
2000). A deletion cassette for tnaA gene, which encodes
tryptophanase, was amplified by PCR using FRT-PKG-
gb2-neo-FRT (Gene Bridges; Heidelberg, Germany) as
template DNA and the following primers: forward 1 (5′-
TGTAATATTCACAGGGATCACTGTAATTAAAATAA
ATGAAGGATTATGTAAATTAACCCTCACTAAAGG
GCG-3′) and reverse 1 (5′-TGTAGGGTAAGAGAGT
GGCTAACATCCTTATAGCCACTCTGTAGTATTAA
TAATACGACTCACTATAGGGCTC-3′). KOD -plus-
DNA polymerase (Toyobo; Osaka, Japan) was used, and
the PCR program was as follows: 94°C for 2 min and 25 cy-
cles each of 94°C for 20 s, 60°C for 15 s, and 68°C for
2 min. According to the manufacturer’s recommendation,
mutant strains were selected and transferred onto Luria
Bertani agar (10 g/L Bacto Tryptone, 5 g/L Bacto Yeast
Extract, 10 g/L NaCl and 15 g/L Bacto Agar) containing
30 μg/mL kanamycin, and the resulting tnaA-deficient
mutant was collected and used as a host for the subse-
quent experiments. Degradation of L-tryptophan and
5-HTP was performed in a reaction mixture contain-
ing 100 mM HEPES-NaOH buffer (pH 7.5), 5 mM L-
tryptophan, 0.1 mM DMPH4, 0.1 mM FeSO4, 50 mM
D-glucose, 1% (v/v) Triton X-100, and E. coli whole
cells (OD660 = 50) in a total volume of 1 mL.
Construction of expression vectors
The gene encoding PAH-L101Y-W180F was amplified
by PCR using the following primers: forward 2 (5′-AT
ATACATATGAACGACCGCGCCGACTTTGTGGTGC-
3′; the Nde I site is underlined) and reverse 2 (5′-
TTCATCTCGAGATTAGACGTCTTCGGTATCCGC
CCATCC-3′; the Xho I site is underlined) from
pEPAH-L101Y-W180F (Kino et al. 2009). The gene
encoding pterin-4α-carbinolamine dehydratase (PCD,
GenBank Protein ID: AAZ35428) was amplified using the
following primers: forward 3 (5′-AATAGCCATGGG
TACCTTGAATCAAGCCCATTGCG-3′; the Nco I site is
underlined) and reverse 3 (5′-AATATGTCGACATTAT
TTGCGGCCTTCGGCGCCACTG-3′; the Sal I site is
underlined) from the chromosomal DNA of P. syringae.
The amplified genes were inserted into the corresponding
restriction site of pETDuet-1 (Novagen; Madison, Wl). The
resulting plasmid was labeled pEDPCD-PAH-L101Y-
W180F and used for the expression of PCD and PAH-
L101Y-W180F genes in E. coli. The gene encoding
dihydropteridine reductase (DPR, GenBank Protein ID:
AAC73679) was amplified by PCR using the following






















Figure 1 Degradation of L-tryptophan and 5-HTP using E. coli
cells. Open circles, L-tryptophan using wild-type E. coli; filled circles,
L-tryptophan using E. coli tnaA disruptant; open squares, 5-HTP using
wild-type E. coli; filled squares, 5-HTP using E. coli tnaA disruptant.
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underlined) and reverse 4 (5′- TGTAATAGCTCGAG
TTTACACTTCGGTTAAGGTGATGTTTTGCG-3′; the
Xho I site is underlined) from the chromosomal DNA of
E. coli K-12 MG1655. The glucose dehydrogenase (GDH,
GenBank Protein ID: CAB12201) gene was amplified
using the following primers: forward 5 (5′-CTA
TAGAATTCGTATCCGGATTTAAAAGGAAAAG-3′; the
EcoR I site is underlined) and reverse 5 (5′-ATTATGTC
GACATTAACCGCGGCCTGCCTGGAATGAAG-3′; the
Sal I site is underlined) from the chromosomal DNA of B.
subtilis. The amplified genes were inserted into the corre-
sponding restriction site of pACYCDuet-1 (Novagen). The
resulting plasmid was labeled pAGDH-DPR and was used
for the expression of GDH and DPR genes in E. coli.
Preparation of recombinant E. coli BL21(DE3) tnaA–
expressing PAH-L101Y-W180F, PCD, DPR and GDH genes
E. coli BL21(DE3) tnaA– harboring pEDPCD-PAH-
L101Y-W180F and pAGDH-DPR was cultivated at 37°C
in LB medium containing 50 μg/mL ampicillin and
30 μg/mL chloramphenicol. Isopropyl-β-D-thiogalacto-
pyranoside (IPTG) was added to the culture when the
OD660 reached 0.5, to a final concentration of 0.1 mM,
and the cells were then cultivated at 25°C with shaking.
After a 20-h induction period, E. coli BL21(DE3) harbor-
ing plasmids were harvested by centrifugation at 5,000 × g
for 5 min at 4°C. The cell pellet was washed twice with
200 mM HEPES-NaOH buffer (pH 8.0) and resuspended
in the same buffer. To confirm the expression of enzymes,
SDS-PAGE analysis was carried out on supernatant of
disrupted cells.
Synthesis of 5-HTP thorough cofactor regeneration
5-HTP was synthesized in a reaction mixture containing
100 mM HEPES-NaOH buffer (pH 8.0), 5 mM L-trypto-
phan, DMPH4 at different concentrations, 0.1 mM FeSO4,
50 mM D-glucose, 1% (v/v) Triton X-100, and E. coli
whole cells (OD660 = 50) in a total volume of 1 mL. The
reaction was performed at 30°C. After the reaction, cells
were removed by centrifugation at 20,000 × g for 5 min at
4°C. The concentration of 5-HTP in the reaction mixture
was determined by high performance liquid chromatog-
raphy as described previously (Kino et al. 2009).
Results
Construction of the E. coli BL21(DE3) tnaA– strain
During the production of 5-HTP, the endogenous
metabolic enzymes of E. coli (e.g., tryptophanase) de-
grade L-tryptophan to indole, pyruvate, and ammonia;
and 5-HTP is degraded to 5-hydroxyindole, pyruvate,
and ammonia (Nakazawa et al. 1972a; Nakazawa et al.
1972b; Watanabe and Snell 1972). We also confirmed
the degradation of 5-HTP as well as of L-tryptophan inthe wild-type E. coli whole cell reaction (Figure 1), and
then attempted to delete the gene encoding tryptopha-
nase (tnaA), which is the enzyme that initially degrades
L-tryptophan, to overcome these drawbacks.
To prevent the degradation of L-tryptophan and 5-
HTP, the tnaA gene of E. coli BL21 (DE3) was disrupted
using the Red/ET recombination system. Consequently,
the degradation of L-tryptophan and 5-HTP was clearly
inhibited by disruption of the tnaA gene of E. coli
(Figure 1), suggesting that this host strain contributes to
enhance 5-HTP production.
Synthesis of 5-HTP catalyzed by PAH without DMPH4
regeneration
To achieve L-tryptophan hydroxylation using PAH-
L101Y-W180F, it is necessary to add the coenzyme
DMPH4 to the reaction mixture. Using E. coli BL21
(DE3) tnaA– whole cells expressing only PAH-L101Y-
W180F gene, 5-HTP was synthesized in the presence of
0.1–5 mM DMPH4 and was observed to increase with
increase in the concentration of DMPH4 up to 18%
(0.9 mM) at 5 mM DMPH4, indicating that synthesis of
5-HTP is coenzyme DMPH4-dependent. We also
attempted to develop higher yield synthesis of 5-HTP by
reduced addition of DMPH4.
Effect of coexpression of the DPR, GDH, and PCD genes
To construct DMPH4 regeneration through oxidation-
reduction reactions, two plasmids were constructed:
pEDPCD-PAH-L101Y-W180F and pAGDH-DPR. Both
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and the genes encoding PAH-L101Y-W180F, PCD, DPR,
and GDH were coexpressed in the same E. coli cells.
SDS-PAGE analysis revealed that all of enzymes were
successfully expressed in E. coli compared to negative
control (Figure 2). Hence, we applied this strain as a
catalyst for L-tryptophan hydroxylation using a whole
cell reaction (Figure 3).
In order to initially regenerate DMPH4 from 6,7-di-
methyl-5,6,7,8-dihydropterine (DMPH2), which is an oxi-
dized form of DMPH4, DPR from E. coli K-12 (Vasudevan
et al. 1988) and PAH-L101Y-W180F were coexpressed in
the same E. coli cells. DPR was selected for DMPH4 regen-
eration because it exhibits tetrahydropterin-dependent
NAD(P)H oxidoreductase activities. This approach re-
sulted in an increase in 5-HTP synthesis compared to that
obtained with PAH-L101Y-W180F alone with 0.1 mM
DMPH4 (Figure 4). Furthermore, 0.35 mM 5-HTP was
synthesized in the presence of DPR with only 0.1 mM
DMPH4, suggesting that DPR served as a DMPH4 regen-
eration enzyme.
To further accelerate DMPH4 regeneration using E.
coli endogenous NAD(P)H, it is necessary to regenerate
NAD(P)H from NAD(P)+ in the E. coli cell. For NAD(P)
H regeneration, GDH from B. subtilis was selected since
it serves as a cofactor in NAD(P)H regeneration.Figure 2 SDS-PAGE analysis of soluble proteins in E. coli cells.
Lanes 1, molecular mass standards with size indicated; 2, soluble
protein of E. coli expressing heterologous genes; 3, soluble protein
of E. coli (negative control). Triangles indicate as follows: filled,
L-phenylalanine 4-hydroxylase; dark gray, glucose dehydrogenase;
light gray, dihydropteridine reductase; open, pterin-4α-carbinolamine
dehydratase.Moreover, GDH has high specific activity and prefers
NADP+ over NAD+ (Yun et al. 2005). Similarly, DPR
prefers NADPH over NADH. Thus, the genes encoding
GDH, DPR, and PAH-L101Y-W180F were coexpressed
in E. coli BL21(DE3) tnaA–. The coexpression of the
GDH gene, in addition to the PAH-L101Y-W180F and
DPR genes in E. coli, led to a 1.6-fold increase in 5-HTP
as compared to that for the PAH-L101Y-W180F and
DPR genes alone, suggesting that NAD(P)H regeneration
stimulated DMPH4 regeneration.
During human pterin regeneration, aromatic amino acid
hydroxylation is followed by the conversion of pterin to
pterine-4α-carbinolamine. Pterine-4α-carbinolamine is
subsequently converted to dihydropteridine, and DPR cat-
alyzes the reduction of dihydropteridine to tetrahydrop-
terin. In this process, PCD catalyzes the dehydration of
pterine-4α-carbinolamine to produce dihydropteridine.
However, pterine-4α-carbinolamine is affected by a non-
enzymatic rearrangement with opening of the pyridine
ring, yielding the 7-substituted pterin (Davis et al. 1991;
Schallreuter et al. 1994). Additionally, in the absence of
PCD, 7-substituted pterin is formed and competes with
the natural cofactor tetrahydropterin for PAH, leading to
a critically reduced hydroxylation rate (Davis et al. 1991).
Therefore, to accelerate DMPH4 regeneration and in-
crease the 5-HTP yield, more PCD was added and the
corresponding gene was coexpressed in E. coli BL21(DE3)
tnaA–. The results of this approach indicated a nearly 11-
fold (0.74 mM) increase in the synthesis yield of 5-HTP
when compared to samples lacking cofactor regeneration
(Figure 4).Optimization of reaction conditions for synthesis of 5-HTP
Enhanced synthesis of 5-HTP was investigated using
PAH-L101Y-W180F, and an oxidation-reduction enzyme
process for DMPH4 regeneration was established. It was
then necessary to optimize the reaction conditions using
E. coli whole cells with the four enzymes coexpressed in
the same E. coli cell.
Effects of pH and temperature on 5-HTP synthesis
were examined over a range of pH values (pH 5–10) and
temperatures (20–50°C). The maximal yield of 5-HTP
was obtained at pH 8.0 and 30°C (Figure 5).
Finally, the effects of DMPH4 concentration (0.1–5 mM)
on 5-HTP synthesis were determined at optimal pH and
temperature. The molar yield of 5-HTP reached 50% when
DMPH4 exceeded 3 mM (Figure 6).Discussion
In the present study, we developed a novel cofactor regen-
eration system for L-tryptophan hydroxylation to synthe-
size 5-HTP. In this coupling system of pterin and NAD(P)






















Figure 3 Scheme of 5-HTP synthesis through cofactor regeneration. PAH, L-phenylalanine 4-hydroxylase; PCD, pterin-4α-carbinolamine
dehydratase; DPR, dihydropteridine reductase; GDH, glucose dehydrogenase.
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necessary for L-tryptophan hydroxylation.
We recently used site-directed mutagenesis to engin-
eer CviPAH, which exhibited high L-tryptophan hydrox-
ylation activity. Comparison of the crystal structures of
CviPAH with human L-tryptophan 5-hydroxylase led to
the hypothesis that L101 and W180 in CviPAH were re-
sponsible for cofactor and substrate affinity, respectively,
and we consequently engineered the CviPAH L101Y-
W180F mutant enzyme (Kino et al. 2009). While higher





















Figure 4 Effects of DMPH4 regeneration enzymes on synthetic
yield of 5-HTP using PAH. The basal reaction condition is described
in the text. In this experiment, 0.1 mM DMPH4 was applied.by CviPAH L101Y-W180F, the cofactor pterin is still es-
sential for the aromatic amino acid hydroxylase reaction,
and because pterin is an expensive reagent for industrial
applications, there is a demand for a more cost-effective
process to provide pterin. To accomplish this, we
focused on developing a pterin-regeneration system.
Additionally, since human pterin recycling enzymes
from the brain and other tissues have been investigated
and it is known that NAD(P)H is necessary for pterin re-
generation, we hypothesized that if this process could be
reconstructed in E. coli, L-tryptophan hydroxylation with
regeneration of the cofactors pterin and NAD(P)H could
be established, leading to efficient 5-HTP synthesis
(Figure 3). NAD(P)H can be regenerated using dehydro-
genase-coupling processes, including GDH, formate
dehydrogenase, and alcohol dehydrogenase; therefore,
we utilized GDH from Bacillus subtilis to regenerate
NAD(P)H and pterin due to its high enzyme activity and
stability.
Currently, 5-HTP is produced by extraction from the
seeds of the African plant G. simplicifolia. Several at-
tempts have been made to synthesize 5-HTP using chem-
ical or enzymatic syntheses; however, these have proven to
be unsuitable from an industrial perspective. Therefore,
we focused our attention on microbial L-phenylalanine 4-
hydroxylase because this enzyme hydroxylates L-trypto-
phan to 5-HTP, and L-phenylalanine to L-tyrosine.
Although engineered CviPAH exhibited high L-trypto-
phan hydroxylation activity, the enzyme required L-tryp-
tophan and equimolar concentrations of the cofactor
pterin, which is an expensive and scarce compound in the
industry. Hence, we proposed and constructed a novel
cofactor regeneration process coupled with amino acid
hydroxylation. Using microbial genome information, we
reconstituted three enzymes, PCD, DPR and GDH, for
pterin regeneration, and coexpressed the corresponding











































Figure 5 Optimal pH and temperature for the synthesis of 5-HTP, using the E. coli whole cell reaction. (a) The reaction conditions, except
for pH and buffer, are described in the text. The following buffers were used: acetate buffer, pH 5.0–5.5; maleate buffer, pH 6.0; MOPS-NaOH
buffer, pH 6.5; HEPES-NaOH buffer, pH 7.0–8.0; Tris–HCl buffer, pH 8.5; borate-NaOH buffer, pH 9.0–10. (b) The reaction conditions, except for
temperature, are described in the text.
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DPR, and GDH was used as a whole cell catalyst, higher
L-tryptophan hydroxylation activity was observed than
that seen with E. coli expressing the gene encoding Cvi-
PAH alone (Figure 4), suggesting that pterin regeneration
was functionally affected.
Indeed, the regeneration process is effective for the
production of 5-HTP to some extent, although this
approach could not effect conversion of all of the avail-














Figure 6 Effect of DMPH4 concentration on the synthesis of
5-HTP, using the E. coli whole cell reaction. Open circles,
L-tryptophan hydroxylation using E. coli tnaA disruptant expressing
PAH gene alone; filled circles, L-tryptophan hydroxylation using
E. coli tnaA disruptant expressing the genes encoding PAH, PCD,
DPR, and GDH.the maximum yield of 5-HTP was 0.74 mM in the pres-
ence of 0.1 mM DMPH4, suggesting that the total turn-
over number is 7.4 mole/mole. On the other hand, the
total turnover number is less than 1 mole/mole in case
of >3 mM DMPH4 addition (Figure 6). Previous studies
suggested that GDH should promote further NAD(P)H
regeneration; however, complete pterin regeneration was
still difficult to achieve, which may be due to instability
of the pterin. Several studies have reported that pterin-
4α-carbinolamine, an oxidized form of pterin, can spon-
taneously convert to an undesirable 7-substituted pterin
(Curtius et al. 1990a; Curtius et al. 1990b; Davis et al.
1991; Thony et al. 2000). Once this 7-substituted
compound is formed, the pterin regeneration cycle is
hampered, since the hydroxylase reaction is partially
uncoupled (Schallreuter et al. 1994). To avoid the forma-
tion of 7-substituted pterin and accelerate pterin regen-
eration, PCD, or “phenylalanine hydroxylase-stimulating
protein” (Hauer et al. 1993; Huang et al. 1973), was
supplied to stimulate the regeneration system. While a
minor stimulatory effect was observed, only a slight in-
crease in 5-HTP was achieved (Figure 4). This effect is
likely due to the unnecessary accumulation of pterin
analog such as 7-substituted pterin, and this problem
must be resolved in order to achieve complete conver-
sion of L-tryptophan to 5-HTP.
In summary, we report the development of a novel
pterin regeneration process for enhanced L-tryp-
tophan hydroxylation. Although the efficiency of
pterin regeneration is expected to improve with fur-
ther enhancements to the regeneration enzymes, this
regeneration process represents a powerful tool for
practical amino acid hydroxylation using aromatic amino
acid hydroxylases, including L-phenylalanine 4-hydroxy-
lase, L-tyrosine 3-hydroxylase, and L-tryptophan 5-
hydroxylase.
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